Altmetric

Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID‐19

File Description SizeFormat 
Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19.pdfFile embargoed until 09 June 20213.44 MBAdobe PDF    Request a copy
Title: Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID‐19
Authors: Arachchillage, DJ
Remmington, C
Rosenberg, A
Xu, T
Passariello, M
Hall, D
Laffan, M
Patel, BV
Item Type: Journal Article
Issue Date: Sep-2020
Date of Acceptance: 3-Jun-2020
URI: http://hdl.handle.net/10044/1/81080
DOI: 10.1111/bjh.16927
ISSN: 0007-1048
Publisher: Wiley
Start Page: e286
End Page: e288
Journal / Book Title: British Journal of Haematology
Volume: 190
Issue: 5
Copyright Statement: © 2020 British Society for Haematology and John Wiley & Sons Ltd. This is the peer reviewed version of the following article, which has been published in final form at https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16927. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: Science & Technology
Life Sciences & Biomedicine
Hematology
Acute Disease
Adult
Anticoagulants
Antithrombins
Betacoronavirus
Cohort Studies
Coronavirus Infections
Female
Humans
Incidence
Male
Middle Aged
Pandemics
Pipecolic Acids
Pneumonia, Viral
Severity of Illness Index
Thrombophilia
Humans
Pneumonia, Viral
Coronavirus Infections
Thrombophilia
Acute Disease
Pipecolic Acids
Antithrombins
Anticoagulants
Severity of Illness Index
Incidence
Cohort Studies
Adult
Middle Aged
Female
Male
Pandemics
Betacoronavirus
1102 Cardiorespiratory Medicine and Haematology
Immunology
Publication Status: Published
Embargo Date: 2021-06-09
Open Access location: https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7300519&blobtype=pdf
Article Number: bjh.16927
Online Publication Date: 2020-06-09
Appears in Collections:Department of Immunology and Inflammation
Department of Surgery and Cancer
Faculty of Medicine
Imperial College London COVID-19